Abstract
We report the case of a perinatally HIV-1-infected child, previously immunologically unresponsive to antiretroviral treatments (including the highly active antiretroviral therapy), who instead developed a vigorous and long-lasting immune response after the highly active antiretroviral therapy was associated with antineoplastic chemotherapy undertaken for a B-cell non-Hodgkin bone lymphoma.
MeSH terms
-
Adolescent
-
Antigens, CD / immunology
-
Antineoplastic Agents / therapeutic use*
-
Antiretroviral Therapy, Highly Active*
-
CD4 Lymphocyte Count
-
HIV Infections / complications
-
HIV Infections / drug therapy*
-
HIV Infections / immunology
-
HIV-1
-
Humans
-
Immunophenotyping
-
Lymphoma, AIDS-Related / complications
-
Lymphoma, AIDS-Related / drug therapy*
-
Lymphoma, AIDS-Related / immunology
-
Lymphoma, B-Cell / complications
-
Lymphoma, B-Cell / drug therapy*
-
Lymphoma, B-Cell / immunology
-
Male
-
Viral Load
Substances
-
Antigens, CD
-
Antineoplastic Agents